Among all mental health condition categories, which has the highest global prevalence?
A: Mood disorders (including depression)
B: Anxiety disorders
C: Substance use disorders
D: Psychotic disorders
Anxiety disorders are the most prevalent mental health condition globally. Their high prevalence reflects both the breadth of the category (spanning numerous distinct disorders) and their early onset, meaning individuals may live with the condition for decades.
Anxiety disorders most commonly have their first onset during which periods of life?
A: Infancy and toddlerhood (0–5 years)
B: Childhood, adolescence, and early adulthood
C: Middle adulthood (35–55 years)
D: Late adulthood (60 years and over)
Anxiety disorders predominantly begin during childhood, adolescence, and early adulthood. Specific phobia and separation anxiety typically onset in childhood; social anxiety disorder peaks in adolescence; GAD and panic disorder more commonly begin in early adulthood, though the overall pattern is one of early life onset.
Compared to men, how much more likely are women to be diagnosed with an anxiety disorder?
A: Equally likely
B: About 1.5 times as likely
C: About twice as likely
D: About three times as likely
Women are approximately twice as likely as men to have an anxiety disorder. The reasons are likely multifactorial, including hormonal influences, differences in cognitive appraisal styles, greater tendency towards internalising responses to stress, and potentially sociocultural factors that affect help-seeking and diagnosis rates.
Anxiety is best understood as a dimensional construct, even though categorical diagnostic criteria remain clinically useful.
Svar: Sant
Anxiety exists on a continuum of severity across the population rather than falling into discrete categories. Diagnostic thresholds in DSM-5 and ICD-10 represent clinically useful cut-points on this dimension — they enable treatment decisions and communication — but the underlying biology and psychology of anxiety operates dimensionally. This is why subclinical anxiety still causes functional impairment, and why individuals can cross thresholds over time.
Which anxiety disorder has the highest lifetime prevalence?
A: Social Anxiety Disorder
B: Generalised Anxiety Disorder
C: Specific Phobia
D: Panic Disorder
Specific Phobia is the most common anxiety disorder, with lifetime prevalence estimates of 6–12%. The high rate partly reflects that most individuals with phobias have more than one, and many phobias cause less overall functional impairment than disorders like GAD or panic disorder — meaning they persist without treatment, accumulating in population estimates.
What is the estimated lifetime prevalence range for Specific Phobia?
A: 1–3%
B: 6–12%
C: 15–20%
D: 25–30%
Lifetime prevalence estimates for Specific Phobia are in the range of 6–12%, making it the most prevalent of the anxiety disorders. Variation between estimates reflects differences in diagnostic criteria versions, interview methods, and the populations studied across international epidemiological surveys.
Most individuals diagnosed with Specific Phobia have more than one phobia.
Svar: Sant
The majority of people with Specific Phobia report fears of multiple types — for example, animal phobia co-occurring with blood-injection-injury phobia. This pattern of multiple phobias within the same individual inflates the disorder's overall prevalence and suggests a shared vulnerability to acquiring conditioned fear responses.
The lifetime prevalence of Social Anxiety Disorder is approximately:
A: 3–5%
B: 6–8%
C: 10%
D: 15–18%
Social Anxiety Disorder has a lifetime prevalence of approximately 10%, making it the second most common anxiety disorder after Specific Phobia. It is associated with significant impairment in occupational functioning, education, and social relationships, and frequently remains undiagnosed because sufferers avoid the very settings where they might seek help.
Compared to other anxiety disorders, Social Anxiety Disorder is notable for which of the following epidemiological features?
A: It has the highest lifetime prevalence of all anxiety disorders
B: It shows less discrepancy in rates between men and women than other anxiety disorders
C: It shows the strongest association with Major Depressive Disorder
D: It is the only anxiety disorder that commonly onsets in adulthood
Social Anxiety Disorder has a less pronounced gender difference than most other anxiety disorders. While women are still somewhat more likely to meet criteria, the 2:1 female-to-male ratio seen in the broader anxiety disorders category is attenuated for social anxiety. This may reflect that social evaluation fears are experienced fairly equally across sexes, or that men with social anxiety are more likely to present with substance use than to seek mental health treatment.
The lifetime prevalence of Generalised Anxiety Disorder (GAD) is approximately:
A: 1–2%
B: 3–5%
C: 7–9%
D: 12–15%
GAD has a lifetime prevalence of approximately 3–5%, placing it below Specific Phobia and Social Anxiety Disorder but above Panic Disorder and Agoraphobia. Despite its relatively lower prevalence, GAD is associated with significant disability, partly because the pervasive and uncontrollable nature of the worry affects virtually all life domains.
Approximately what proportion of individuals with one anxiety disorder will meet criteria for another anxiety disorder at some point in their lives?
A: Around 1 in 10
B: Around 1 in 4
C: As many as half
D: Around 3 in 4
As many as half of individuals with one anxiety disorder will have another anxiety disorder at some point in their life. This high rate of within-category comorbidity is consistent with the view that a general anxiety/negative affect vulnerability underlies the anxiety disorders, with specific disorders representing different expressions of that shared diathesis.
Anxiety disorders frequently co-occur with Major Depressive Disorder.
Svar: Sant
Comorbidity between anxiety disorders and depression is well established and clinically important. The two categories share genetic risk factors, neurobiological substrates, and cognitive vulnerabilities such as negative affectivity. In clinical settings, the majority of individuals presenting with one condition will have significant symptoms of the other, affecting treatment planning and prognosis.
Among the anxiety disorders, the particularly strong association with Major Depressive Disorder is seen with:
A: Specific Phobia
B: Panic Disorder
C: Social Anxiety Disorder
D: Generalised Anxiety Disorder
The association between GAD and Major Depressive Disorder is particularly strong — to the point that some researchers have questioned whether they are truly distinct conditions or reflect a common internalising disorder. They share overlapping diagnostic criteria (e.g., concentration difficulties, fatigue, sleep disturbance), high genetic overlap, and frequently co-occur temporally. Treating one often leads to improvement in the other.
How does comorbidity with alcohol and substance-use disorders compare to comorbidity with depression in the context of anxiety disorders?
A: Substance-use comorbidity is more common than depression comorbidity
B: Substance-use comorbidity is equally common as depression comorbidity
C: Substance-use comorbidity also occurs, but to a lesser extent than comorbidity with depression
D: Substance-use disorders are not associated with anxiety disorders
Alcohol and substance-use disorders do co-occur with anxiety disorders — often reflecting self-medication of anxiety symptoms — but this comorbidity is less pronounced than the anxiety-depression relationship. The relationship with substances is also more complex in direction: anxiety can precede substance use (as a driver), or substance use and withdrawal can generate anxiety, making the causal pathway bidirectional.
Epidemiologi vid ångestsyndrom
Among all mental health condition categories, which has the highest global prevalence?
Om det här quizet
Testa din kunskap om den globala förekomsten av ångestsyndrom — vilka är vanligast, vilka grupper drabbas mest, hur störningar samexisterar och hur komorbiditetsmönstren ser ut med depression och substansbruk. Baserat på Craske & Stein (2016), Lancet.